Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason D Theis

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Kidney International|January 11, 2013
The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosisSamih H Nasr, Samar M Said, Anthony M Valeri, et al.
Human Pathology|October 16, 2025
Dual amyloidosis: A clinicopathologic and proteomic analysis of 111 patientsJoanna C Dalland, Surendra Dasari, Jason D Theis, et al.
Blood Cancer Journal|March 7, 2019
Two types of amyloidosis presenting in a single patient: a case seriesM Hasib Sidiqi, Ellen D McPhail, Jason D Theis, et al.
Blood|January 14, 2014
Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United StatesOana M Mereuta, Jason D Theis, Julie A Vrana, et al.
The American Journal of Pathology|August 9, 2011
Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-IDorota Rowczenio, Ahmet Dogan, Jason D Theis, et al.
Journal of the American Society of Nephrology : JASN|June 15, 2016
Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CIISamih H Nasr, Surendra Dasari, Linda Hasadsri, et al.
American Journal of Clinical Pathology|August 29, 2025
Gallbladder amyloidosis is often unexpected and may have systemic implicationsCatherine E Hagen, Surendra Dasari, Jason D Theis, et al.
Journal of the American Society of Nephrology : JASN|January 5, 2017
Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique PhenotypeSamih H Nasr, Surendra Dasari, John R Mills, et al.
Kidney International|January 24, 2014
Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosisSamar M Said, Sanjeev Sethi, Anthony M Valeri, et al.
Kidney International|March 6, 2024
Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathyBenjamin Madden, Raman Deep Singh, Mark Haas, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Kidney International|January 11, 2013
The diagnosis and characteristics of renal heavy-chain and heavy/light-chain amyloidosis and their comparison with renal light-chain amyloidosisSamih H Nasr, Samar M Said, Anthony M Valeri, et al.
Human Pathology|October 16, 2025
Dual amyloidosis: A clinicopathologic and proteomic analysis of 111 patientsJoanna C Dalland, Surendra Dasari, Jason D Theis, et al.
Blood Cancer Journal|March 7, 2019
Two types of amyloidosis presenting in a single patient: a case seriesM Hasib Sidiqi, Ellen D McPhail, Jason D Theis, et al.
Blood|January 14, 2014
Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United StatesOana M Mereuta, Jason D Theis, Julie A Vrana, et al.
The American Journal of Pathology|August 9, 2011
Amyloidogenicity and clinical phenotype associated with five novel mutations in apolipoprotein A-IDorota Rowczenio, Ahmet Dogan, Jason D Theis, et al.
Journal of the American Society of Nephrology : JASN|June 15, 2016
Novel Type of Renal Amyloidosis Derived from Apolipoprotein-CIISamih H Nasr, Surendra Dasari, Linda Hasadsri, et al.
American Journal of Clinical Pathology|August 29, 2025
Gallbladder amyloidosis is often unexpected and may have systemic implicationsCatherine E Hagen, Surendra Dasari, Jason D Theis, et al.
Journal of the American Society of Nephrology : JASN|January 5, 2017
Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique PhenotypeSamih H Nasr, Surendra Dasari, John R Mills, et al.
Kidney International|January 24, 2014
Characterization and outcomes of renal leukocyte chemotactic factor 2-associated amyloidosisSamar M Said, Sanjeev Sethi, Anthony M Valeri, et al.
Kidney International|March 6, 2024
Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathyBenjamin Madden, Raman Deep Singh, Mark Haas, et al.
Pageof 9